Mycobacterial lipoarabinomannan: An extraordinary lipoheteroglycan with profound physiological effects

Glycobiology

Volumn 8, Issue 2, 1998, Pages 113-120

  Chatterjee, Delphi ^a   Khoo, Kay Hooi ^b  

^a Immunology and Pathology   (United States)

^b INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

Author keywords

CD1; Ethambutol; Lipoarabinomannan; Lipomannan; Mycobacteria; Phosphatidylinositol mannosides; Tuberculosis

Indexed keywords

ARABINOMANNAN; ETHAMBUTOL; GLYCAN DERIVATIVE; PHOSPHATIDYLINOSITOL; TUBERCULOSTATIC AGENT;

ACYLATION; BACTERIUM ADHERENCE; DRUG RESISTANCE; IMMUNOPATHOGENESIS; MACROPHAGE; MYCOBACTERIUM; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TUBERCULOSIS;

ANIMALS; ANTIGENS, BACTERIAL; CARBOHYDRATE SEQUENCE; HUMANS; LIPOPOLYSACCHARIDES; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM;

ACTINOBACTERIA (CLASS); BACTERIA (MICROORGANISMS); CORYNEBACTERINEAE; MYCOBACTERIUM; UNCULTURED ACTINOMYCETE;

EID: 0031951727     PISSN: 09596658     EISSN: None     Source Type: Journal    
DOI: 10.1093/glycob/8.2.113     Document Type: Review

References (69)

1. Adams, L.B., Fukutomi, Y. and Krahenbuhl, J.L. (1993) Regulation of murine macrophage effector functions by lipoarabinomannan from mycobacterial strains with different degrees of virulence. Infect. Immun., 61, 4173-4181.
2. Azuma, I., Kimura, H., Ninaka, T., Aoki, I. and Yamamura, Y. (1968) Chemical and immunological studies on mycobacterial polysaccharides. I. Purification and properties of polysaccharides from human tubercle bacilli. J. Bacteriol., 95, 263-271.
3. Barnes, P.F., Chatterjee, D., Brennan, P.J., Rea, T.H. and Modlin, R.L. (1992a) Tumor necrosis factor production in patients with leprosy. Infect. Immun., 60, 1441-1446.
4. Barnes, P.F., Chatterjee, D., Abrams, J.S., Lu, S., Wang, E., Yamamura, M., Brennan, P.J. and Modlin, R.L. (1992b) Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan: relationship to chemical structure. J. Immunol., 149, 541-547.
5. Beckman, E.M., Melián, A., Behar, S.M., Sieling, P.A., Chatterjee, D., Furlong, S.T., Matsumoto, R., Rosat, J.P., Modlin, R.L. and Porcelli, S.A. (1996) CD1c restricts responses of mycobacteria-specific T cells - evidence for antigen presentation by a second member of the human CD1 family. J. Immunol., 157, 2795-2803.
6. Belanger, A.E., Besra, G.S., Ford, M.E., Mikusová, K., Belisle, J.T., Brennan, P.J. and Inamine, J.M. (1996) The embAB genes of Mycobacterium avium encode an arabinosyl transferase involved in cell wall arabinan biosynthesis that is the target for the antimycobacterial drug ethambutol. Proc. Natl. Acad. Sci. USA, 93, 11919-11924.
7. Berman, J.S., Blumenthal, R.L., Kornfield, H., Cook, J.A., Cruikshank, W.W., Vermeulen, M.W., Chatterjee, D., Belisle, J.T. and Fenton, M.J. (1996) Chemotactic activity of mycobacterial lipoarabinomannans for human blood T lymphocytes in vitro. J. Immunol., 156, 3828-3835.
8. 1H nuclear magnetic resonance spectroscopy. Biochemistry, 34, 4257-4266.
9. Besra, G.S., Morehouse, C.B., Rittner, C.M., Waechter, C.J. and Brennan, P.J. (1997) Early steps in the biosynthesis of LAM. J. Biol. Chem., 272, 18460-18466.
10. Brennan, P.J. and Ballou, C.E. (1967) The biosynthesis of mannophosphoinositides by Mycobacterium phlei. 242, 3046-3056.
11. Brennan, P.J. and Nikaido, H. (1995) The envelope of mycobacteria. Annu. Rev. Biochem., 64, 29-63.
12. Brennan, P.J., Hunter, S.W., McNeil, M., Chatterjee, D. and Daffe, M. (1990) Reappraisal of the chemistry of mycobacterial cell walls, with a view to understandung the roles of individual entities in disease processes. In Ayoub, E.M., Cassell, G.H., Branche, W.C., Jr. and Henry, T.J. (eds.) Microbial Determinants of Virulence and Host Response. American Society for Microbiology, Washington, DC, pp. 55-75.
13. Chan, J., Fan, X., Hunter, S.W., Brennan, P.J. and Bloom, B.R. (1991) Lipoarabinomannan, a possible virulence factor involved in persistence Mycobacterium tuberculosis within macrophages. Infect. Immun., 59, 1755-1761.
14. Chargraff, E. and Schaefer, W. (1935) A specific polysaccharide from the bacillus Calmette-Guerin (BCG). J. Biol. Chem., 112, 393-405.
15. Chatterjee, D., Khoo, K.-H., McNeil, M.R., Dell, A., Morris, H.R. and Brennan, P.J. (1993) Structural definition of the non-reducing termini of mannose-capped LAM from Mycobacterium tuberculosis through selective enzymatic degradation and fast atom bombardment-mass spectrometry. Glycobiology, 3, 497-506.
16. Chatterjee, D., Bozic, C.M., McNeil, M. and Brennan, P.J. (1991) Structural features of the arabinan component of the lipoarabinomannan of Mycobacterium tuberculosis. J. Biol. Chem., 266, 9652-9660.
17. Chatterjee, D., Hunter, S.W., McNeil, M. and Brennan, P.J. (1992a) Lipoarabinomannan. Multiglycosylated form of the mycobacterial mannosylphophatidylinositols. J. Biol. Chem., 267, 6228-6233.
18. Chatterjee, D., Lowell, K., Rivoire, B., McNeil, M. and Brennan, P.J. (1992b) Lipoarabinomannan of Mycobacterium tuberculosis. Capping with mannosyl residues in some strains. J. Biol. Chem., 267, 6234-6239.
19. Chatterjee, D., Roberts, A.D., Lowell, K., Brennan, P.J. and Orme, I.M. (1992c) Structural basis of capacity of lipoarabinomannan to induce secretion of tumor necrosis factor. Infect. Immun., 60, 1249-1253.
20. Chatterjee, D., Khoo, K.-H., McNeil, M.R., Dell, A., Morris, H.R. and Brennan, P.J. (1993) Structural definition of the non-reducing termini of mannose-capped LAM from Mycobacterium tuberculosis through selective enzymatic degradation and fast atom bombardment-mass spectrometry. Glycobiology, 3, 497-506.
21. Deng, L., Mikusová, K., Robuck, K.G., Scherman, M., Brennan, P.J. and McNeil, M.R. (1995) Recognition of multiple effects of ethambutol on metabolism of mycobacterial cell envelope. Antimicrob. Agents Chemother., 39, 694-701.
22. Gaylord, H., Brennan, P.J., Young, D.B. and Buchanan, T.M. (1987) Most Mycobacterium leprae carbohydrate-reactive monoclonal antibodies are directed to lipoarabinomannan. Infect. Immun., 55, 2860-2863.
23. Gilleron, M., Nourrédine, H., Adam, O., Constant, P., Venisse, A., Rivière, M. and Puzo, G. (1997) Mycobacterium smegmatis Phosphoinositols-Glyceroarabinomannans. J. Biol. Chem., 272, 117-124.
24. Hunter, S.W. and Brennan, P.J. (1990) Evidence for the presence of a phosphatidylinositol anchor on the lipoarabinomannan and lipomannan of Mycobacterium tuberculosis. J. Biol. Chem., 265, 9272-9279.
25. Hunter, S.W., Gaylord, H. and Brennan, P.J. (1986) Structure and antigenicity of the phosphorylated lipopolysaccharide antigens from the leprosy and tubercle bacilli. J. Biol. Chem., 261, 12345-12351.
26. Jullien, D., Stenger, S., Ernst, W.A. and Modlin, R.L. (1997) CD1 presentation of microbial nonpeptide antigens to T cells. J. Clin. Invest., 99, 2071-2074.
27. Kaplan, G., Gandhi, R.R., Weinstein, D.E., Levis, W.R., Patarroyo, M.E., Brennan, P.J. and Cohn, Z.A. (1987) Mycobacterium leprae antigen-induced suppression of T cell proliferation in vitro. J. Immunol., 138, 3028-3034.
28. Khoo, K.-H., Dell, A., Morris, H.R., Brennan, P.J. and Chatterjee, D. (1995a) Structural definition of acylated phosphatidylinositol mannosides from Mycobacterium tuberculosis: definition of a common anchor for lipomannan and lipoarabinomannan. Glycobiology, 5, 117-127.
29. Khoo, K.-H., Dell, A., Morris, H.R., Brennan, P.J. and Chatterjee, D. (1995b) Inositol phosphate capping of the non-reducing termini of lipoarabinomannan from rapidly growing strains of Mycobacterium. Mapping of the non-reducing termini of LAMs. J. Biol. Chem., 270, 12380-12389.
30. Khoo, K.H., Douglas, E., Azadi, P., Inamine, J.M., Besra, G.S., Mikusová, K., Brennan, P.J. and Chatterjee, D. (1996) Truncated structural variants of lipoarabinomannan in ethambutol drug-resistant strains of Mycobacterium smegmatis - inhibition of arabinan biosynthesis by ethambutol. J. Biol. Chem., 271, 28682-28690.
31. Lee, Y.C. and Ballou, C.E. (1964) Structural studies on the myo-inositol mannosides from the glycolipids of Mycobacterium tuberculosis and Mycobacterium phlei. J. Biol. Chem., 239, 1316-1327.
32. Lee, R.E., Mikusová, K., Brennan, P.J. and Besra, G.S. (1995) Synthesis of the mycobacterial arabinose donor β-D-arabinofuranosyl-1-monophosphoryldecaprenol, development of a basic arabinosyl-transferase assay, and identification of ethambutol as an arabinosyl transferase inhibitor. J. Am. Chem. Soc., 117, 11829-11832.
33. Lemassu, A. and Daffé, M. (1994) Structural features of the exocellular polysaccharides of Mycobacterium tuberculosis. Biochem. J., 297, 351-357.
34. Leopold, K. and Fischer, W. (1993) Molecular analysis of the lipoglycans of Mycobacterium tuberculosis. Anal. Biochem., 208, 57-64.
35. Llangumaran, S., Arni, S., Poincelet, M., Theler, J.-M., Brennan, P.J., Nasir-Ud-Din and Hoessli, D.C. (1995) Integration of mycobacterial lipoarabinomannans into glycosylphosphatidylinositol-rich domains of lymphomonocytic cell plasma membranes J. Immunol., 138, 3028-3034.
36. McNeil, M.R. and Brennan, P.J. (1991) Structure, function, and biogenesis of the cell envelope of mycobacteria in relation to bacterial physiology, pathogenesis, and drug resistance; some thoughts and possibilities arising from recent structural information. Res. Microbiol., 142, 451-463.
37. McNeil, M.R., Robuck, K., Harter, M. and Brennan, P.J. (1994) Enzymatic evidence for the presence of a critical terminal hexaarabinofuranoside in the cell walls of Mycobacterium tuberculosis. Glycobiology, 4, 165-173.
38. Melián, A., Beckman, E.M., Porcelli, S.A. and Brenner, M.B. (1996) Antigen presentation by CD1 and MHC-encoded class I-like molecules. Curr. Opin. Immunol., 8, 82-88.
39. Menzel, E.O. and Heidelberger, M. (1939) Specific and non-specific cell polysaccharides of a bovine strain of tubercle bacillus. J. Biol. Chem., 127, 221-236
40. Mikusová, K., Slayden, R.A., Besra, G.S. and Brennan, P.J. (1995) Biogenesis of the mycobacterial cell wall and the site of action on ethambutol. Antimicrob. Agents Chemother., 39, 2484-2489.
41. Misaki, A., Azuma, I. and Yamamura, Y. (1977) Structural and immunochemical studies on d-arabino-D-mannans of Mycobacterium tuberculosis and other Mycobacterium species. J. Biochem (Tokyo), 82, 1759-1770.
42. Moreno, C., Mehlert, A. and Lamb, J. (1988) The inhibitory effects of mycobacterial lipoarabinomannan and polysaccharides upon polyclonal and monoclonal human T cell proliferation. Clin. Exp. Immunol., 74, 206-210.
43. Moreno, C., Taverne, J., Mehlert, A., Bate, C.A.W., Brealey, R.J., Meager, A., Rook, G.A.W. and Playfair, J.H.L. (1989) Lipoarabinomannan from Mycobacterium tuberculosis induces the production of tumor necrosis factor from human and murine macrophages. Clin. Exp. Immunol., 76, 240-245.
44. Ohashi, M. (1970) Studies on the chemical structure of serologically active arabinomannan from mycobacteria, Jap. J. Exp. Med., 40, 1-4.
45. Pangborn, M.C. and McKinney, J.A. (1966) Purification of serologically active phosphoinositides of Mycobacterium tuberculosis. J. Lipid Res., 7, 627-633.
46. Peterson, P.K., Hu. S., Weng, W.S., Kravitz, F.H., Molitor, T.W., Chatterjee, D. and Chao, C.C. (1995) Thalidomide inhibits tumor necrosis factor-α production by lipopolysaccharide and lipoarabinomannan-stimulated human microglial cells. J. Infect. Dis., 172, 1137-1140.
47. Porcelli, S. (1995) The CD1 family: a third lineage of antigen presenting molecules. Adv. Immunol., 59, 1-98.
48. Prinzis, S., Chatterjee, D. and Brennan, P.J. (1993) Structure and antigenicity of lipoarabinomannan from Mycobacterium bovis BCG. J. Gen. Microbiol., 139, 2649-2658.
49. Prigozy, T.I., Sieling, P.A., Clemens, D., Stewart, P.L., Behar, S.M., Porcelli, S.A., Brenner, M.B., Modlin, R.L. and Kronenberg, M. (1997) The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1b molecules. Immunity, 6, 187-197.
50. Rastogi, N. (1991) Recent observations concerning structure and function relationships in the mycobacterial cell envelope: elaboration of a model in terms of mycobacterial pathogenicity, virulence and drug resistance. Res. Microbiol., 142, 464-476.
51. Roach, T.I.A., Barton, C.H., Chatterjee, D. and Blackwell, J.M. (1993) Macrophage activation: lipoarabinomannan from avirulent and virulent strains of Mycobacterium tuberculosis differentially induces the early genes c-fos, KC, JE, and tumor necrosis factor-α. J. Immunol., 150, 1886-1896.
52. Roach, T.I.A., Barton, C.H., Chatterjee, D., Liew, F.Y. and Blackwell, J.M. (1995) Opposing effects of interferon-g on iNOS and IL10 expression in LPS and mycobacterial LAM stimulated macrophages. Immunology, 85, 106-113.
53. Schlesinger, L.S. (1993) Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J. Immunol., 150, 2920-2925.
54. Schlesinger, L.S., Hull, S.R. and Kaufman, T.M. (1994) Binding of the terminal mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human macrophages. J. Immunol., 152, 4070-4079.
55. Schlesinger, L.S., Kaufman, T.M., Iyer, S., Hull, S.R. and Marchiando, L.K. (1996) Differences in mannose receptor-mediated uptake of lipoarabinomannan from virulent and attenuated strains of Mycobacterium tuberculosis by human macrophages. J. Immunol., 157, 4568-4575.
56. Seibert, F.B. and Watson, D.W. (1941) Isolation of the polysaccharides and nucleic acid of tuberculin by electrophoresis. J. Biol.Chem., 140, 55-69.
57. Sibley, L.D., Hunter, S.W., Brennan, P.J. and Krahenbuhl, J.L. (1988) Mycobacterial lipoarabinomannan inhibits gamma interferon-mediated activation of macrophages. Infect. Immun., 56, 1232-1236.
58. Sieling, P.A., Chatterjee, D., Porcelli, S.A., Prigozy, T.I., Mazzacaro, R.J., Soriano, T., Bloom, B.R., Brenner, M.B., Kronenberg, M., Brennan, P.J. and Modlin, R.L. (1995) CD1-restricted T cell recognition of microbial lipoglycans. Science, 269, 227-230.
59. Takayama, K. and Kilburn, J.O. (1989) Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis. Antimicrob. Agents Chemother., 33, 1493-1499.
60. Tsumita, I., Matsumoto, R. and Mizuno, D. (1960) Chemical and biological properties of the haemagglutination antigen, a lipopolysaccharide, of Mycobacterium tuberculosis var.hominis,Jpn. J. Med. Sci. Biol., 13, 131-138.
61. Venisse, A., Berjeaud, J.-M., Chaurand, P., Gilleron, M. and Puzo, G. (1993) Structural features of lipoarabinomannan from Mycobacterium bovis BCG. Determination of molecular mass by laser desorption mass spectrometry. J. Biol. Chem., 268, 12401-12411.
62. Venisse, A., Rivière, M., Vercauteren, J. and Puzo, G. (1995) Structural analysis of the mannan region of lipoarabinomannan from Mycobacterium bovis BCG. Heterogeneity in phosphorylation state. J. Biol. Chem., 270, 15012-15021.
63. Weber, P.L. and Gray, G.L. (1979) Structural and immunochemical characterization of the acidic arabinomannan of Mycobacterium smegmatis. Carbohydr. Res., 74, 259-278.
64. Xu, S., Cooper, A., Sturgill-Koszycki, S., van Heyningen, T., Chatterjee, D., Orme, I., Allen, P. and Russel, D.G. (1994) Intracellular trafficking in Mycobacterium tuberculosis and Mycobacterium avium-infected macrophages. J. Immunol., 153, 2568-2578.
65. Yokoyama, K. and Ballou, C.E. (1989) Synthesis of α1→6-mannooligosaccharide in M.smegmatis. J. Biol. Chem., 264, 21621-21628.
66. Yoshida, A. and Koide, Y. (1997) Arabinofuranosyl-terminated and mannosylated lipoarabinomannans from Mycobacterium tuberculosis induce different levels of interleukin-12 expression in murine macrophages. Infect. Immun., 65, 1953-1955.
67. Zhang, Y., Doerfler, M., Lee, T.C., Guillemin, B. and Rom, W.N. (1993) Mechanisms of stimulation of interleukin-1 beta and tumour necrosis factor-alpha by Mycobacterium tuberculosis components. J. Clin. Invest., 91, 2076-2083.
68. Zhang, Y., Broser, M. and Rom, W.N. (1994) Activation of the interleukin 6 gene by Mycobacterium tuberculosis or lipopolysaccharide is mediated by nuclear factors NF-IL6 and NF-kappa B. Proc. Natl. Acad. Sci. USA, 91, 2225-2229.
69. Zhang, Y., Broser, M., Cohen, H., Bodkin, M., Law, K., Reibman, J. and Rom, W.N. (1995) Enhanced interleukin-8 release and gene expression in macrophages after exposure to Mycobacterium tuberculosis and its components. J. Clin. Invest., 95, 586-592.